SCHEMBL19332451

SCHEMBL19332451

CCOC(=O)c1cc2c(Cl)c(C)ccc2[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.57
ALDH1A1 P00352 7/20 0.56
KDM4E B2RXH2 6/20 0.56
RAB9A P51151 6/20 0.56
HPGD P15428 5/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
HSD17B10 Q99714 2/20 0.56
NPC1 O15118 4/20 0.52
LMNA P02545 2/20 0.52
HTT P42858 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
HRH3 Q9Y5N1 1/20 0.52
MMP13 P45452 5/20 0.51
MMP2 P08253 3/20 0.51
GAA P10253 3/20 0.51
MAPT P10636 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
GLA P06280 1/20 0.51
ATM Q13315 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30525427 0.89 ALOX15 (0.57) ALOX15ALDH1A1KDM4ERAB9AHPGD
SCHEMBL699665 0.89 ALOX15 (0.57) ALOX15ALDH1A1KDM4ERAB9AHPGD
SCHEMBL1883225 0.86 ALOX15 (0.58) ALOX15ALDH1A1KDM4ERAB9AHPGD
SCHEMBL30193757 0.86 ALOX15 (0.58) ALOX15ALDH1A1KDM4ERAB9AHPGD
SCHEMBL6739125 0.85 KDM4E (0.58) ALOX15ALDH1A1KDM4ERAB9AHPGD
SCHEMBL19331227 0.85 CYP1A2 (0.45) ALOX15ALDH1A1KDM4ERAB9AHPGD
SCHEMBL6594500 0.85 ALDH1A1 (0.55) ALOX15ALDH1A1KDM4ERAB9AHPGD
SCHEMBL23049582 0.84 ALOX15 (0.55) ALOX15ALDH1A1KDM4ERAB9AHPGD
SCHEMBL17429439 0.83 KDM4E (0.56) ALOX15ALDH1A1KDM4ERAB9AHPGD
SCHEMBL7954222 0.83 ALOX15 (0.57) ALOX15ALDH1A1KDM4ERAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017156181-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-09-14 WO disclosed